Evidence map›Paper›PMID 41701535›Full record

ArticleThe Journal of clinical investigation2026

Characterization of elite controllers with an undetectable intact HIV DNA reservoir.

Jana Blazkova, Brooke D Kennedy, Jesse S Justement, Victoria Shi, Adeline Sewack, Maegan R Manning, Sonali Dasari, Kathleen Gittens, Susan Moir, Mark Connors and 2 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jana BlazkovaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Brooke D KennedyLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Jesse S JustementLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Victoria ShiLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Adeline SewackLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Maegan R ManningLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Sonali DasariLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Kathleen GittensClinical Center, NIH, Bethesda, Maryland, USA.
Susan MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Mark ConnorsLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Stephen A MiguelesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.
Tae-Wook ChunLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID) and.

Funding

NIH HHS
6 · The paper itself

Abstract

Some people with HIV control the virus without medication. This study identified a rare group lacking detectable HIV reservoirs, offering important clues for developing future cures.

Indexed as

DNA, ViralElite ControllersHIV-1HIV InfectionsHumansDNA, ViralAIDS/HIVCellular immune responseImmunologyMolecular geneticsT cellsVirology

Identifiers

PMID41701535
PMCPMC13078864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.